latest news releases from the newsroom
RedChip Companies Inc.
RedChip Companies, Inc. to Ring the NASDAQ Closing Bell On Thursday, August 21st
ORLANDO, Fla., Aug. 12, 2008 (PRIME NEWSWIRE) -- RedChip Companies, Inc., an international financial public relations and equity research firm specializing in the small capitalization sector, announced today that Dave Gentry, president and CEO, will preside over the NASDAQ closing bell ceremony on Thursday, August 21, 2008. Members of RedChip's management team and guests will join Mr. Gentry at the ceremony, which will take place at the NASDAQ MarketSite in Times Square and will be broadcast live.
Generex Biotechnology Corp.
Generex Announces Enrollment of Over 150 Patients in Phase III Trial of Generex Oral-lyn
WORCESTER, Mass., Aug. 12, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has enrolled over 150 patients in the Company's pivotal Phase III clinical trial of Generex Oral-lyn(tm), its flagship proprietary oral insulin spray product. Of those patients, over 100 have been dosed. There are 55 sites in the United States, Canada, Bulgaria, Russia, Poland and Ukraine actively screening and enrolling patients, including 39 clinical trial sites where patients are being dosed. Generex Oral-lyn(tm) has been shipped to all of the sites.